Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Saflutan
Tafluprost is a prostaglandin analog used to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, thereby lowering IOP. Tafluprost is classified as a prostaglandin F2α analog.
For reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Outcome:
Additive IOP lowering effect
Mechanism:
Similar mechanism of action
Outcome:
Additive IOP lowering effect
Mechanism:
Different mechanisms of action, synergistic effect
Outcome:
Potential for reduced IOP lowering effect
Mechanism:
Aspirin can interfere with prostaglandin synthesis
Most likely new formulation: Sustained-release implant (Year 2026, 70% confidence)
Based on current usage trends and clinical trial data, Tafluprost is expected to maintain its current regulatory status with a 95% likelihood over the next 5 years.
Prostaglandin Analog, Antiglaucoma Agent
Prostaglandin F2α analog